(Q53660956)

English

Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Mitchell Kronenberg

7

object named as

Mitchell Kronenberg

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

author name string

Yoshinori Ikarashi

1

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Akira Iizuka

2

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Yumie Koshidaka

3

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Yuji Heike

4

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Yoichi Takaue

5

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Mitsuzi Yoshida

6

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Hiro Wakasugi

8

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

116

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

1

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

30-37

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

NKT cells: facts, functions and fallacies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

NKT cells - conductors of tumor immunity?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Sea-level fingerprinting as a direct test for the source of global meltwater pulse IA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2005.02193.X

21 January 2018

The unconventional lifestyle of NKT cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802404

29 September 2018

Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1802404

29 September 2018

Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokines production of U5A2-13-positive T cells by stimulation with glycolipid alpha-galactosylceramide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NKT cells and tumor immunity—a double-edged sword

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of alpha -galactosylceramide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A thymic precursor to the NK T cell lineage

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis of V alpha 14i NKT cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16108815

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2005.02193.X

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 May 2018

http://europepmc.org/abstract/MED/16108815

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53660956&oldid=1483063870"